{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:20:19Z","timestamp":1783016419023,"version":"3.54.6"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Reviews in Mutation Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mrrev.2026.108600","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:52:13Z","timestamp":1780480333000},"page":"108600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic instability in canine mammary tumors: A comparative focus on loss of heterozygosity and microsatellite alterations with human breast cancer"],"prefix":"10.1016","volume":"798","author":[{"given":"Faiz Muhammad","family":"Khand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barkat Ali","family":"Jatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel Ahmed","family":"Lakho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4151-7192","authenticated-orcid":false,"given":"Ambreen","family":"Leghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2026.108600_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302231","article-title":"Incidence rates of the most common canine tumors based on data from the Swiss canine cancer registry (2008\u20132020)","volume":"19","author":"Dhein","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mrrev.2026.108600_bib2","first-page":"521","article-title":"Pathology-based animal cancer registry of Abruzzo and Molise regions (Central Italy): a ten-year retrospective study (2014-2023)","volume":"11","author":"Di Teodoro","year":"2024","journal-title":"Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314292","article-title":"Epidemiological investigation and surgical treatment of canine mammary tumors in Dalian, China, from 2019 to 2023","volume":"19","author":"Jing","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mrrev.2026.108600_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13028-018-0417-1","article-title":"Current biomarkers of canine mammary tumors","volume":"60","author":"Kaszak","year":"2018","journal-title":"Acta Vet. Scand."},{"key":"10.1016\/j.mrrev.2026.108600_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s13193-023-01773-1","article-title":"Molecular subtypes and Ki-67 index in breast carcinoma with special emphasis on triple negative breast cancer. A 3-year study in a tertiary care center","volume":"16","author":"Pai","year":"2025","journal-title":"Indian. J. Surg. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib6","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v5i1.1364","article-title":"DNA methylation profiles for breast cancer subtype classifications: A translational study from microarray to methylation-specific PCR (MSP)","volume":"5","author":"Panigoro","year":"2025","journal-title":"Narra J."},{"key":"10.1016\/j.mrrev.2026.108600_bib7","first-page":"1941","article-title":"Correlation between SWE parameters and histopathological features and immunohistochemical biomarkers in invasive breast cancer","volume":"49","author":"Liu","year":"2024","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.mrrev.2026.108600_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40064-015-0790-4","article-title":"Pollutants in pet dogs: a model for environmental links to breast cancer","volume":"4","author":"S\u00e9v\u00e8re","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.mrrev.2026.108600_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fvets.2020.00439","article-title":"Comparative analysis of the development of acquired radioresistance in canine and human mammary cancer cell lines","volume":"7","author":"Gray","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/REP-13-0086","article-title":"Isolation, genetic manipulation, and transplantation of canine spermatogonial stem cells: progress toward transgenesis through the male germ-line","volume":"146","author":"Harkey","year":"2013","journal-title":"Reproduction"},{"key":"10.1016\/j.mrrev.2026.108600_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/vco.12935","article-title":"Leading the pack: best practices in comparative canine cancer genomics to inform human oncology","volume":"21","author":"London","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120632","article-title":"Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model","volume":"269","author":"Bushnell","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mrrev.2026.108600_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/2326-6066.CIR-18-0751","article-title":"CCR4 blockade depletes regulatory T cells and prolongs survival in a canine model of bladder cancer","volume":"7","author":"Maeda","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","article-title":"Microsatellite instability: a review of what the oncologist should know","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.mrrev.2026.108600_bib15","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.16","article-title":"Mismatch repair is a double-edged sword in the battle against microsatellite instability","volume":"24","author":"Miller","year":"2022","journal-title":"Expert. Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.mrrev.2026.108600_bib16","article-title":"Canine mammary carcinomas: a comparative analysis of altered gene expression","volume":"3","author":"Kabir","year":"2015","journal-title":"Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12917-020-2247-4","article-title":"Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy","volume":"16","author":"Thumser-Henner","year":"2020","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib18","first-page":"145","article-title":"A highly conserved region in BRCA2 suppresses the RAD51-interaction activity of BRC repeats","volume":"10","author":"Zhu","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/vco.12542","article-title":"The canine RAD51 mutation leads to the attenuation of interaction with PALB2","volume":"18","author":"Uemura","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib20","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1038\/s41467-021-24836-9","article-title":"Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds","volume":"12","author":"Alsaihati","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrrev.2026.108600_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41598-023-27664-7","article-title":"PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia","volume":"13","author":"Arendt","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrrev.2026.108600_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13058-023-01705-5","article-title":"Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs","volume":"25","author":"Watson","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib23","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/ani11072079","article-title":"Dysregulation of PI3K\/Akt\/PTEN pathway in canine mammary tumor","volume":"11","author":"Kim","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.mrrev.2026.108600_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/ani11020365","article-title":"An immunohistochemical study of the PTEN\/AKT pathway involvement in canine and feline mammary tumors","volume":"11","author":"Asproni","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.mrrev.2026.108600_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.24425\/pjvs.2019.127080","article-title":"Characterisation of genome-wide structural aberrations in canine mammary tumours using single nucleotide polymorphism (SNP) genotyping assay","volume":"22","author":"Surdyka","year":"2019","journal-title":"Pol. J. Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.819293","article-title":"ABCC9 is downregulated and prone to microsatellite instability on ABCC9tetra in canine breast cancer","volume":"8","author":"Hao","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/diagnostics10020104","article-title":"Microsatellite instability and MMR genes abnormalities in canine mammary gland tumors","volume":"10","author":"Khand","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.mrrev.2026.108600_bib28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1177\/03009858211022704","article-title":"Mismatch repair deficiency in canine neoplasms","volume":"58","author":"Inanaga","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.mrrev.2026.108600_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/life12060851","article-title":"Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 variant detection in canine formalin-fixed paraffin-embedded mammary tumors","volume":"12","author":"Di Giacomo","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.mrrev.2026.108600_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266623","article-title":"Clinical validation of a next-generation sequencing-based multi-cancer early detection \"liquid biopsy\" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study","volume":"17","author":"Flory","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.mrrev.2026.108600_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008049","article-title":"Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity","volume":"15","author":"Adamovich","year":"2019","journal-title":"PLoS. Genet."},{"key":"10.1016\/j.mrrev.2026.108600_bib32","first-page":"488","article-title":"Endogenous Leu332Gln mutation in p53 disrupts the tetramerization ability in a canine mammary gland tumor cell line","volume":"40","author":"Ochiai","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mrrev.2026.108600_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1157878","article-title":"Analysis of cell-free DNA concentration, fragmentation patterns and TP53 gene expression in mammary tumor-bearing dogs: a pilot study","volume":"10","author":"Guil-Luna","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126371","article-title":"Canine mammary tumours are affected by frequent copy number aberrations, including amplification of MYC and loss of PTEN","volume":"10","author":"Borge","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.mrrev.2026.108600_bib35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1186\/s12885-024-13239-w","article-title":"Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma","volume":"24","author":"Deckwirth","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mrrev.2026.108600_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/vms3.1366","article-title":"Genetic analysis of PALB2 gene WD40 domain in canine mammary tumour patients","volume":"10","author":"\u00c7\u0131ld\u0131r","year":"2024","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.702889","article-title":"CEACAM gene family mutations associated with inherited breast cancer risk - A comparative oncology approach to discovery","volume":"12","author":"Huskey","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.mrrev.2026.108600_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5829.2010.00250.x","article-title":"Identification of genetic variation in 11 candidate genes of canine mammary tumour","volume":"9","author":"Borge","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4161\/15592294.2014.970080","article-title":"MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria","volume":"9","author":"Crucianelli","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.mrrev.2026.108600_bib40","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/PAS.0b013e3182627787","article-title":"DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non\u2013triple-negative tumors","volume":"36","author":"Wen","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.mrrev.2026.108600_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3205","article-title":"Breast carcinoma and Lynch syndrome: Molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases","volume":"14","author":"Lotsari","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib42","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.annonc.2021.08.2154","article-title":"Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: olympiAD","volume":"32","author":"Hodgson","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41523-021-00361-2","article-title":"Value of the loss of heterozygosity to BRCA1 variant classification","volume":"8","author":"Santana Dos Santos","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.mrrev.2026.108600_bib44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-020-05569-7","article-title":"The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1)","volume":"180","author":"Sorscher","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mrrev.2026.108600_bib45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s42003-019-0669-y","article-title":"Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53","volume":"2","author":"Ghaleb","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mrrev.2026.108600_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13058-020-01370-y","article-title":"Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells","volume":"22","author":"Ghaleb","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.31557\/APJCP.2019.20.1.269","article-title":"PTEN genetic and epigenetic alterations define distinct subgroups in North Indian breast cancer patients","volume":"20","author":"Kazim","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.mrrev.2026.108600_bib48","first-page":"1387","article-title":"Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression","volume":"34","author":"Kechagioglou","year":"2014","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4161\/cbt.21346","article-title":"The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients","volume":"13","author":"Tanic","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mrrev.2026.108600_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cancergencyto.2010.01.019","article-title":"Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer","volume":"199","author":"Silva Soares","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.mrrev.2026.108600_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cancers17010008","article-title":"BRCA and beyond: impact on therapeutic choices across cancer","volume":"17","author":"Tan","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.mrrev.2026.108600_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-024-07502-8","article-title":"BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors","volume":"209","author":"D\u00e4ster","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mrrev.2026.108600_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13148-024-01787-8","article-title":"BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: implementation in liquid biopsy in the era of precision medicine","volume":"16","author":"Panagopoulou","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.mrrev.2026.108600_bib54","article-title":"Metabolomics integrated genomics approach: understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1\/EGFR\/PI3k\/PTEN crosstalk","volume":"14","author":"Kadry","year":"2024","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.mrrev.2026.108600_bib55","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00109-024-02499-5","article-title":"Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments","volume":"102","author":"Valenti","year":"2024","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.mrrev.2026.108600_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101196","article-title":"Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells","volume":"79","author":"Wu","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.mrrev.2026.108600_bib57","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3892\/or.2014.3502","article-title":"Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model","volume":"32","author":"Roy","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mrrev.2026.108600_bib58","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1292\/jvms.21-0006","article-title":"Identification of the core motif of the BRCA2C-terminal RAD51-binding domain by comparing canine and human BRCA2","volume":"83","author":"Yoshikawa","year":"2021","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib59","first-page":"607","article-title":"Identifying the risk factors for malignant mammary tumors in dogs: a retrospective study","volume":"10","author":"da Silva","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib60","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.7150\/thno.59280","article-title":"GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer","volume":"11","author":"Bai","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.mrrev.2026.108600_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1179808","article-title":"GATA-3 expression and its correlation with prognostic factors and survival in canine mammary tumors","volume":"10","author":"Diniz-Gon\u00e7alves","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib62","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41467-020-16936-9","article-title":"NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation","volume":"11","author":"Miao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrrev.2026.108600_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1139\/cjpp-2023-0031","article-title":"PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis","volume":"102","author":"Zaza","year":"2024","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.mrrev.2026.108600_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313343","article-title":"Whole blood gene expression analysis of spontaneous hypertriglyceridemia in dogs suggests an underlying pro-thrombotic process","volume":"19","author":"Baker","year":"2024","journal-title":"PLoS. One"},{"key":"10.1016\/j.mrrev.2026.108600_bib65","first-page":"518","article-title":"Overcoming challenges in interdisciplinary collaboration between human and veterinary medicine","volume":"11","author":"Han","year":"2024","journal-title":"Vet. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-017-4542-8","article-title":"Canine invasive mammary carcinomas as models of human breast cancer. Part 2: Immunophenotypes and prognostic significance","volume":"167","author":"Abadie","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mrrev.2026.108600_bib67","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s11259-024-10400-5","article-title":"Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: First study","volume":"48","author":"da Fonseca","year":"2024","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.mrrev.2026.108600_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12917-024-04085-w","article-title":"Establishment of canine mammary gland tumor cell lines harboring PI3K\/Akt activation as a therapeutic target","volume":"20","author":"Park","year":"2024","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.mrrev.2026.108600_bib69","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.3390\/ijms25147923","article-title":"Bicalutamide enhances conventional chemotherapy in in vitro and in vivo assays using human and canine inflammatory mammary cancer cell lines","volume":"25","author":"Crespo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2026.108600_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2023.26.e4","article-title":"Canine as a comparative and translational model for human mammary tumor","volume":"26","author":"Kwon","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.mrrev.2026.108600_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/vco.12996","article-title":"Molecular and pathobiology of canine mammary tumour: defining a translational model for human breast cancer","volume":"22","author":"Oliveira-Lopes","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/vco.12863","article-title":"Molecular phenotyping of malignant canine mammary tumours: detection of high-risk group and its relationship with clinicomolecular characteristics","volume":"21","author":"Zamani-Ahmadmahmudi","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.mrrev.2026.108600_bib73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcpa.2013.09.006","article-title":"Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study","volume":"150","author":"Sleeckx","year":"2014","journal-title":"J. Comp. Pathol."}],"container-title":["Mutation Research - Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574226000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574226000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:23:26Z","timestamp":1783013006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574226000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S1383574226000165"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2026.108600","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic instability in canine mammary tumors: A comparative focus on loss of heterozygosity and microsatellite alterations with human breast cancer","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2026.108600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108600"}}